Genomictree Inc. (228760) — Net Asset Momentum
Genomictree Inc. (228760) recorded a net asset momentum of -7.2% as of December 2025, with net assets of ₩115.31 Billion KRW. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See shareholders equity of Genomictree Inc. for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Genomictree Inc. Net Asset Momentum (2020–2025)
This chart tracks Genomictree Inc.'s year-over-year net asset growth across 6 annual reporting periods from 2020 to 2025. The most recent momentum reading is -7.2%, with net assets of ₩115.31 Billion KRW as of December 2025. For live market cap and overall valuation, see market value of Genomictree Inc..
Annual Net Asset History for Genomictree Inc. (2020–2025)
The table below shows the complete annual net asset history for Genomictree Inc. from 2020 to 2025, covering 6 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check how tangible is Genomictree Inc.'s equity to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (KRW) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | ₩115.31 Billion | ₩120.76 Billion | ₩5.45 Billion | ▼ -7.2% |
| 2024 | ₩124.32 Billion | ₩130.68 Billion | ₩6.36 Billion | ▼ -0.6% |
| 2023 | ₩125.03 Billion | ₩132.84 Billion | ₩7.81 Billion | ▲ +16.8% |
| 2022 | ₩107.05 Billion | ₩162.91 Billion | ₩55.86 Billion | ▼ -7.0% |
| 2021 | ₩115.10 Billion | ₩177.15 Billion | ₩62.05 Billion | ▲ +20.8% |
| 2020 | ₩95.26 Billion | ₩117.90 Billion | ₩22.64 Billion | — |